Correction: Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer

Affiliations

• ¹ Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA.
• ² University of Arkansas for Medical Sciences, Little Rock, AR, USA.
• ³ Smilow Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA.
• ⁴ Division of Gynecologic Oncology, Mercy Clinic, St. Louis, MO, USA.
• ⁵ Smilow Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA. alessandro.santin@yale.edu.